Francis Knuettel II 4
4 · Pelthos Therapeutics Inc. · Filed Jul 7, 2025
Insider Transaction Report
Form 4
Francis Knuettel II
CFO, Treas & Secty
Transactions
- Award
Stock Option
2025-07-02+102,000→ 145,074 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (102,000 underlying) - Award
Restricted Stock Units
2025-07-02+33,472→ 33,472 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (33,472 underlying)
Footnotes (3)
- [F1]On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 33,472 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
- [F2]On July 2, 2025, the Reporting Person was granted stock options to purchase 102,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and quarterly thereafter in equal installments over a period of two (2) years.
- [F3]The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.